Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
17 Maio 2024 - 1:00PM
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on
patients treated by ear, nose and throat (ENT) and allergy
specialists, today announced that members of its management team
will present a company overview and business update at the H.C.
Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on
May 20, 2024 at 11:30 a.m. ET.
To listen to a webcast of the presentation live, please visit
the Investors page of the Optinose website.
A replay of the webcast will be available for 30 days following
the conclusion of the event.
About OptinoseOptinose is a specialty
pharmaceutical company focused on serving the needs of patients
cared for by ear, nose and throat (ENT) and allergy specialists. To
learn more, please visit www.optinose.com or follow us on X
and LinkedIn.
Optinose Investor ContactJonathan
Neelyjonathan.neely@optinose.com267.521.0531
OptiNose (NASDAQ:OPTN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
OptiNose (NASDAQ:OPTN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024